PATH MD INC. NPI 1124316138

NPI Details

PATH MD, INC. is a clinical medical laboratory in Los Angeles, CA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. PATH MD, INC. NPI is 1124316138. The provider is registered as an organization entity type.

The provider's business location address is:

8158 BEVERLY BLVD
LOS ANGELES, CA
ZIP 90048-513
Phone: (424) 245-7284
Fax: (323) 944-0639

The provider's authorized official is Kamran Jamshidinia .
The authorized official title is Secretary and has the following contact phone number (310) 657-2203.

The CLIA number assigned to this NPI record is 05D2045519 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source (HCPCS:G2024)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Cell examination of urine, computer-assisted (HCPCS:88121)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets (HCPCS:87505)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets (HCPCS:87507)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Test for detection of gastrointestinal disease-causing organism using amplified probe (HCPCS:0097U)
• Detection test by immunoassay technique for clostridium difficile toxins (stool pathogen) (HCPCS:87324)
• Detection test by immunoassay technique for other organism (HCPCS:87449)
• Cell examination of urine, manual (HCPCS:88120)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)
• Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
• Pap test (HCPCS:88141)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)

The enumeration date for this NPI number is 7/12/2011 and was last updated on 6/4/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.